Biggest News Aggregation in the World
๐Ÿ“ฐ William Bliar News

William Bliar News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from William Bliar. Real-time updates on events, politics, business and more.

Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule - CRISPR Therapeutics (NASDAQ:CRSP), Vertex Pharmaceuticals (NASDAQ:VRTX)

FDA approves CRISPR Therapeutics/Vertex's Casgevy a gene-edited cell therapy for transfusion-dependent beta-thalassemia. Vertex's swift launch strategy targets a network of treatment centers across the U.S.
William Blair William Bliar Vertex Pharmaceutical Incorporated Bluebird Bio Inc Healthcare Products Regulatory Agency Synergie Medication Collective

This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis - Enovis (NYSE:ENOV)

William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth, especially in sub-categories such as extremities, which are growing rapidly due to
William Blair William Bliar Enovis Corp

Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug - Lantheus Holdings (NASDAQ:LNTH)

Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c
Biopharma Globalinc William Blair William Bliar Lantheus Holdings Inc Lantheus Holdings Market Perform

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest - Exelixis (NASDAQ:EXEL)

Thursday, Exelixis Inc (NASDAQ: EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data and Safety Monitoring Board (DSMB) unanimously recommended to unblind and stop the phase 3 CABINET pivotal trial early due to a dramatic improvement in efficacy that was 
Andy Hsieh Exelixis Inc William Bliar William Blair Alexandra Ramsey Alliance For Clinical Trials In Oncology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science